Healthcare
Siemens Healthineers AG(SMMNY)
Live Price
Offline$19.70
-0.20% today
1Y Change
-25.96%
Window
Jun 23, 2025 โ Jun 12, 2026
- Market Cap
- $38.95B
- Revenue Growth
- -1.5%
- EPS Growth
- +3.4%
- Dividend Yield
- 2.9%
Coverage: 245 bars ยท Jun 23, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Siemens Healthineers AG (SMMNY) is a Healthcare stock with a market cap of $38.95B and listed on PNK. The stock last traded around $19.70 and down 26.0% across the available one-year price window (Jun 23, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of -1.5%, EPS growth of +3.4%, a dividend yield of 2.9%. What stands out right now is revenue -1.5%, EPS +3.4%, free cash flow +20.4% with operating margin 14.7% and ROIC 7.3%. The dividend matters to the case here, with a current yield around 2.9%. Valuation is more restrained than many high-expectation growth names at P/E 18.4 and price/sales 1.7. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines SMMNY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-1.5% vs +7.6% peer median
Operating Margin
Below sector median
+14.7% vs +19.4% peer median
P/E
Below sector median
18.4 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 7, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -1.5% and EPS is at +3.4%, with operating margin around 14.7%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 2.9%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -1.5% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 7, 2026 | โ | -0.4% | -0.9% | +0.2% |
2026 Feb 5, 2026 | +9.9% | +0.5% | -3.8% | -5.4% |
2025 Nov 5, 2025 | -22.9% | -2.0% | +0.3% | -4.8% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SMMNY
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SMMNY Max Drawdown
-32.74%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SMMNY and SPY.
Company Overview
Siemens Healthineers AG
Other OTC
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.
- Leadership
- Bernhard Montag
- IPO Date
- May 14, 2018
- Employees
- 73.8k
- Street Address
- Siemensstr. 3
- Mailing
- Forchheim, 91301
- Region
- Forchheim, DE
- Reporting Currency
- USD
- Investor Line
- 49 9131 84 3385
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 18.4
- EV/EBITDA
- 11.4
- Price/Sales
- 1.7
- Price/Book
- 2.1
Growth
- Revenue
- -1.5%
- EPS
- +3.4%
- Free Cash Flow
- +20.4%
Profitability
- Gross Margin
- 38.4%
- Operating Margin
- 14.7%
- Net Margin
- 9.1%
- ROE
- 11.6%
- ROIC
- 7.3%
Balance Sheet
- Debt/Equity
- 0.82
- Current Ratio
- 1.04
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.